92 related articles for article (PubMed ID: 25862859)
1. Effect of perioperative treatment with a hypoxia-inducible factor-1-alpha inhibitor in an orthotopic surgical mouse model of thyroid cancer.
Cha W; Kim DW; Kim SD; Jeon EH; Jeong WJ; Ahn SH
Anticancer Res; 2015 Apr; 35(4):2049-54. PubMed ID: 25862859
[TBL] [Abstract][Full Text] [Related]
2. Targeting HIF1α peri-operatively increased post-surgery survival in a tongue cancer animal model.
Ahn SH; Choi JY; Kim DW; Lee DY; Jeon EH; Jeong WJ; Paik JH
Ann Surg Oncol; 2015 Sep; 22(9):3041-8. PubMed ID: 25564169
[TBL] [Abstract][Full Text] [Related]
3. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
[TBL] [Abstract][Full Text] [Related]
4. HIF1α in Tumorigenesis of Adenoid Cystic Carcinoma.
Lim YS; Cha W; Park MW; Jeong WJ; Ahn SH
Anticancer Res; 2017 Feb; 37(2):599-606. PubMed ID: 28179306
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
6. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of Pulsatilla koreana extract in anaplastic thyroid cancer via apoptosis and anti-angiogenesis.
Park BH; Jung KH; Son MK; Seo JH; Lee HS; Lee JH; Hong SS
Mol Med Rep; 2013 Jan; 7(1):26-30. PubMed ID: 23135100
[TBL] [Abstract][Full Text] [Related]
8. The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model.
Scholz A; Wagner K; Welzel M; Remlinger F; Wiedenmann B; Siemeister G; Rosewicz S; Detjen KM
Gut; 2009 Feb; 58(2):261-70. PubMed ID: 18829975
[TBL] [Abstract][Full Text] [Related]
9. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis.
Joshi S; Singh AR; Zulcic M; Durden DL
Mol Cancer Res; 2014 Oct; 12(10):1520-31. PubMed ID: 25103499
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer.
Sutendra G; Dromparis P; Kinnaird A; Stenson TH; Haromy A; Parker JM; McMurtry MS; Michelakis ED
Oncogene; 2013 Mar; 32(13):1638-50. PubMed ID: 22614004
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo.
Luong QT; O'Kelly J; Braunstein GD; Hershman JM; Koeffler HP
Clin Cancer Res; 2006 Sep; 12(18):5570-7. PubMed ID: 17000694
[TBL] [Abstract][Full Text] [Related]
12. Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma.
Liu F; Wang P; Jiang X; Tan G; Qiao H; Jiang H; Krissansen GW; Sun X
Cancer Sci; 2008 Oct; 99(10):2055-61. PubMed ID: 19016766
[TBL] [Abstract][Full Text] [Related]
13. Toll-Iike Receptor-3 Activation Enhances Malignant Traits in Human Breast Cancer Cells Through Hypoxia-inducible Factor-1α.
Scatozza F; D'Amore A; Fontanella RA; DE Cesaris P; Marampon F; Padula F; Ziparo E; Riccioli A; Filippini A
Anticancer Res; 2020 Oct; 40(10):5379-5391. PubMed ID: 32988857
[TBL] [Abstract][Full Text] [Related]
14. β‑catenin nuclear translocation induced by HIF‑1α overexpression leads to the radioresistance of prostate cancer.
Luo Y; Li M; Zuo X; Basourakos SP; Zhang J; Zhao J; Han Y; Lin Y; Wang Y; Jiang Y; Lan L
Int J Oncol; 2018 Jun; 52(6):1827-1840. PubMed ID: 29658569
[TBL] [Abstract][Full Text] [Related]
15. Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes.
Straight AM; Oakley K; Moores R; Bauer AJ; Patel A; Tuttle RM; Jimeno J; Francis GL
Cancer Chemother Pharmacol; 2006 Jan; 57(1):7-14. PubMed ID: 16001179
[TBL] [Abstract][Full Text] [Related]
16. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
18. Combination Efficacy of Astragalus membranaceus and Curcuma wenyujin at Different Stages of Tumor Progression in an Imageable Orthotopic Nude Mouse Model of Metastatic Human Ovarian Cancer Expressing Red Fluorescent Protein.
Yin G; Tang D; Dai J; Liu M; Wu M; Sun YU; Yang Z; Hoffman RM; Li L; Zhang S; Guo X
Anticancer Res; 2015 Jun; 35(6):3193-207. PubMed ID: 26026079
[TBL] [Abstract][Full Text] [Related]
19. Over expression of hypoxia-inducible factor-1alpha in renal and bladder cancer cells increases tumorigenic potency.
Kondo Y; Hamada J; Kobayashi C; Nakamura R; Suzuki Y; Kimata R; Nishimura T; Kitagawa T; Kunimoto M; Imura N; Hara S
J Urol; 2005 May; 173(5):1762-6. PubMed ID: 15821583
[TBL] [Abstract][Full Text] [Related]
20. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients.
Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J
J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
